ER Beta Symposium, 16-17 May 2011
Therapeutic Potential of ERβ as Drug Target.
Scientific data at the cutting edge in the field of ERβ and its therapeutic applications was presented and discussed by key researchers from the global scientific community at the symposium.
Organizing committee:
Jan-Åke Gustafsson, M.D., Ph.D., University of Houston, Houston, USA
Marie Österlund, Ph.D., Karo Bio AB, Huddinge, Sweden
Stefan Nilsson, Ph.D., Karo Bio AB, Huddinge, Sweden
